Annual dialysis data report 2019, JSDT Renal Data Registry, Norio Hanafusa; Masanori Abe; Nobuhiko Joki; Tetsuya Ogawa; Eiichiro Kanda; Kan Kikuchi; Shunsuke Goto; Masatomo Taniguchi; Shigeru Nakai; Toshihide Naganuma; Takeshi Hasegawa; Junichi Hoshino; Kenichiro Miura; Atsushi Wada; Yoshiaki Takemoto, Renal Replacement Therapy, 9(1):47, 2023年12月
Association between serum iron markers, iron supplementation, and cardiovascular morbidity in pre-dialysis chronic kidney disease., Hasegawa Takeshi;Imaizumi Takahiro;Hamano Takayuki;Murotani Kenta;Fujii Naohiko;Komaba Hirotaka;Ando Masahiko;Maruyama Shoichi;Nangaku Masaomi;Nitta Kosaku;Hirakata Hideki;Isaka Yoshitaka;Wada Takashi;Fukagawa Masafumi, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
38(12):2713 - 2722, 2023年11月,
原著,
DOI:10.1093/ndt/gfad096 Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis., Murashima Miho;Fujii Naohiko;Goto Shunsuke;Hasegawa Takeshi;Abe Masanori;Hanafusa Norio;Fukagawa Masafumi;Hamano Takayuki, Clinical kidney journal,
16(11):1957 - 1964, 2023年09月,
原著,
DOI:10.1093/ckj/sfad223 Efficacy and safety of drug therapy for the prevention and treatment of chemotherapy-induced peripheral neuropathy: a protocol for a systematic review and network meta-analysis., Sato Miki Takenaka;Hasegawa Takeshi;Noma Hisashi;Sugita Hideki;Ota Erika, BMJ open,
13(9):e070645, 2023年09月,
原著,
DOI:10.1136/bmjopen-2022-070645 Anti-vascular endothelial growth factor biosimilars for macular degeneration, Tomiko Sunaga; Masayuki Maeda; Takeshi Hasegawa; Andrew N. Mason; Hisashi Noma; Erika Ota, Cochrane Database of Systematic Reviews,
2023(8), 2023年08月,
査読あり,
DOI:https://doi.org/10.1002/14651858.CD015804 Clinical utility of diaphragmatic ultrasonography for mechanical ventilator weaning in adults: A study protocol for systematic review and meta-analysis., Tashiro Naonori;Hasegawa Takeshi;Nishiwaki Hiroki;Ikeda Takashi;Noma Hisashi;Levack William;Ota Erika, Health science reports,
6(7):e1378, 2023年07月,
総説,
DOI:10.1002/hsr2.1378 Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association., Hoshino Junichi;Abe Masanori;Hamano Takayuki;Hasegawa Takeshi;Wada Atsushi;Nakai Shigeru;Hanafusa Norio;Masakane Ikuto;Nitta Kosaku, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
38(5):1309 - 1317, 2023年05月,
原著,
DOI:10.1093/ndt/gfac297 Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis., Suzuki Taihei;Nishiwaki Hiroki;Watanabe Yoshitaka;Abe Yoshifusa;Noma Hisashi;Ota Erika;Honda Hirokazu;Hasegawa Takeshi, BMJ open,
13(5):e070345, 2023年05月,
DOI:10.1136/bmjopen-2022-070345 Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis., Maeda Masayuki;Hasegawa Takeshi;Noma Hisashi;Ota Erika, BMJ open,
13(4):e069166, 2023年04月,
DOI:10.1136/bmjopen-2022-069166 Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study., Hamano Takayuki;Imaizumi Takahiro;Hasegawa Takeshi;Fujii Naohiko;Komaba Hirotaka;Ando Masahiko;Nangaku Masaomi;Nitta Kosaku;Hirakata Hideki;Isaka Yoshitaka;Wada Takashi;Maruyama Shoichi;Fukagawa Masafumi, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
38(2):384 - 395, 2023年02月,
原著,
DOI:10.1093/ndt/gfac134 Clinical effectiveness of telepharmacy services in patients with non- communicable diseases in ambulatory care settings (Protocol), Sugita H; Sato MT; Hasegawa T; Noma H; Ota E; Toyoda S, Cochrane Database of Systematic Reviews,
Issue 2(CD015136), 2023年02月,
総説,
査読あり,
DOI:https://doi.org/10.1002/14651858.CD015136 Dialysis therapy, 2021 year in review PD, 長谷川 毅;伊藤 恭彦, 日本透析医学会雑誌,
55(12):743 - 745, 2022年12月,
総説,
DOI:10.4009/jsdt.55.743 Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association., Junichi Hoshino; Masanori Abe; Takayuki Hamano; Takeshi Hasegawa; Atsushi Wada; Shigeru Nakai; Norio Hanafusa; Ikuto Masakane; Kosaku Nitta, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022年10月
【腎疾患における臨床研究の進歩】国際データベース研究の動向 DOPPS研究, 長谷川 毅, 腎と透析, 93(3):431 - 435, 2022年09月
【腎代替療法のすべて】(第9章)透析患者の合併症 不眠・睡眠障害, 長谷川 毅, 腎と透析, 92(増刊):494 - 496, 2022年06月
An investigation into possible sex differences in Association of Haemoglobin with survival among Haemodialysis patients in the J-DOPPS cohort., Hanafusa Norio;Tu Charlotte;McCullough Keith;Bieber Brian;Pisoni Ronald L;Robinson Bruce M;Hasegawa Takeshi;Nangaku Masaomi, Nephrology (Carlton, Vic.),
27(10):795 - 803, 2022年05月,
原著,
DOI:10.1111/nep.14046 Erythropoiesis-stimulating agents for preventing acute kidney injury, Hiroki Nishiwaki; Yoshifusa Abe; Takeshi Hasegawa; William M.M. Levack; Hisashi Noma; Erika Ota, Cochrane Database of Systematic Reviews,
2022(5), 2022年05月,
査読あり,
DOI:https://doi.org/10.1002/14651858.CD014820 Regular weighing to prevent excessive gestational weight gain: a study protocol for a systematic review and meta-analysis., Matsushita Tomomi;Honda Aiko;Hasegawa Takeshi;Inoue Eisuke;Noma Hisashi;Ota Erika, Systematic reviews,
11(1):104, 2022年05月,
査読あり,
DOI:10.1186/s13643-022-01977-6 Association between the use of exchange devices for peritoneal dialysis fluids and peritonitis incidence: A nationwide cohort study., Hasegawa T, Noma H, Hamano T, Abe M, Wada A, Honda H, Ito Y, Masakane I, Nitta K., Perit Dial Int,
42(2):177 - 184, 2022年03月,
原著,
査読あり,
DOI:10.1177/08968608211051591 Biopsy-proven CKD etiology and outcomes: Chronic Kidney Disease Japan Cohort (CKD-JAC) study., Takayuki Hamano; Takahiro Imaizumi; Takeshi Hasegawa; Naohiko Fujii; Hirotaka Komaba; Masahiko Ando; Masaomi Nangaku; Kosaku Nitta; Hideki Hirakata; Yoshitaka Isaka; Takashi Wada; Shoichi Maruyama; Masafumi Fukagawa, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022年03月
Effect of systemic bisphosphonate administration on patients with periodontal disease: a systematic review and meta-analysis protocol., Koide Yoko;Kataoka Yu;Hasegawa Takeshi;Ota Erika;Noma Hisashi, BMJ open,
12(3):e057768, 2022年03月,
原著,
査読あり,
DOI:10.1136/bmjopen-2021-057768 Annual dialysis data report of the 2018 JSDT Renal Data Registry: dementia, performance status, and exercise habits, Kosaku Nitta; Shigeru Nakai; Ikuto Masakane; Norio Hanafusa; Shunsuke Goto; Masatomo Taniguchi; Takeshi Hasegawa; Atsushi Wada; Takayuki Hamano; Junichi Hoshino; Nobuhiko Joki; Keichi Yamamoto; Kenichiro Miura; Masanori Abe; Hidetomo Nakamoto; Kazuyuki Maeno; Tetsuya Kawata; Chikara Oyama; Koji Seino; Toshinobu Sato; Shigeru Sato; Minoru Ito; Junichiro Kazama; Atsushi Ueda; Osamu Saito; Tetsuo Ando; Tomonari Ogawa; Hiroo Kumagai; Hiroyuki Terawaki; Ryoichi Ando; Masaki Abe; Tetsuya Kashiwagi; Chieko Hamada; Yugo Shibagaki; Nobuhito Hirawa; Hisaki Shimada; Yoichi Ishida; Hitoshi Yokoyama; Ryoichi Miyazaki; Mizuya Fukasawa; Yuji Kamijyo; Teppei Matsuoka; Akihiko Kato; Noriko Mori; Yasuhiko Ito; Hirotake Kasuga; Sukenari Koyabu; Tetsuro Arimura; Tetsuya Hashimoto; Masaaki Inaba; Terumasa Hayashi; Tomoyuki Yamakawa; Shinichi Nishi; Akira Fujimori; Tatsuo Yoneda; Shigeo Negi; Akihisa Nakaoka; Takafumi Ito; Hitoshi Sugiyama; Takao Masaki; Yutaka Nitta; Kazuyoshi Okada; Masahito Yamanaka; Masaharu Kan; Kazumichi Ota; Masahito Tamura; Koji Mitsuiki; Yuji Ikeda; Masaharu Nishikido; Akira Miyata; Tadashi Tomo; Shoichi Fujimoto; Tsuyoshi Nosaki; Yoshinori Oshiro, Renal Replacement Therapy, 7(1), 2021年12月
Interventions to increase access to long-acting reversible contraceptives, Tomomi Matsushita; Takeshi Hasegawa; Hisashi Noma; Erika Ota; Victoria B. Chou; Yoshiyuki Okada, Cochrane Database of Systematic Reviews, 2021(11), 2021年11月
Cohort profile: A super-elderly population-based cohort in Japan (the Sukagawa Study), Toru Naganuma; Sei Takahashi; Taro Takeshima; Noriaki Kurita; Kenji Omae; Takashi Yoshioka; Tsuyoshi Ohnishi; Fumihito Ito; Shingo Fukuma; Sugihiro Hamaguchi; Shunichi Fukuhara; Takeshi Hasegawa; Nobuyuki Yajima; Kakuya Niihata; Hidekazu Iida; Susumu Kobayashi; Sho Sasaki; Hiroki Nishiwaki; Ryoji Tominaga, International Journal of Epidemiology, 50(3):727 - 727h, 2021年07月
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus., Hasegawa Takeshi;Zhao Junhui;Bieber Brian;Zee Jarcy;Pisoni Ronald L;Robinson Bruce M;Hanafusa Norio;Nangaku Masaomi, Kidney & blood pressure research, 46(3), 2021年04月, 原著, 査読あり
Added value of clinical prediction rules for bacteremia in hemodialysis patients: An external validation study, Sho Sasaki; Yoshihiko Raita; Minoru Murakami; Shungo Yamamoto; Kentaro Tochitani; Takeshi Hasegawa; Kiichiro Fujisaki; Shunichi Fukuhara, PLoS ONE, 16(2 February):e0247624, 2021年02月
Aldosterone antagonists for people with chronic kidney disease requiring dialysis., HASEGAWA Takeshi;NISHIWAKI Hiroki;OTA Erika;LEVACK WM;NOMA Hisashi, Cochrane Database Syst Rev, 2(2):CD013109, 2021年02月, 原著, 査読あり
Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study, Tomoko Usui; Junhui Zhao; Douglas S. Fuller; Norio Hanafusa; Takeshi Hasegawa; Hiroshi Fujino; Takanobu Nomura; Jarcy Zee; Eric Young; Bruce M. Robinson; Masaomi Nangaku, Nephrology, 26(1):46 - 53, 2021年01月
Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients, Nidhi Sukul; Angelo Karaboyas; Philipp A. Csomor; Thilo Schaufler; Warren Wen; Frédérique Menzaghi; Hugh C. Rayner; Takeshi Hasegawa; Issa Al Salmi; Saeed M.G. Al-Ghamdi; Fitsum Guebre-Egziabher; Pablo Antonio Ureña-Torres; Ronald L. Pisoni, Kidney Medicine, 3(1):42 - 53.e1, 2021年01月
Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients' conditions among hemodialysis patients with diabetes: A 3-year nationwide cohort study, Junichi Hoshino; Masanori Abe; Takayuki Hamano; Takeshi Hasegawa; Atsushi Wada; Yoshifumi Ubara; Kenmei Takaichi; Shigeru Nakai; Ikuto Masakane; Kosaku Nitta, BMJ Open Diabetes Research and Care, 8(1), 2020年10月
Annual dialysis data report for 2018, JSDT Renal Data Registry: Survey methods, facility data, incidence, prevalence, and mortality, Kosaku Nitta; Shunsuke Goto; Ikuto Masakane; Norio Hanafusa; Masatomo Taniguchi; Takeshi Hasegawa; Shigeru Nakai; Atsushi Wada; Takayuki Hamano; Junichi Hoshino; Nobuhiko Joki; Masanori Abe; Keiichi Yamamoto; Hidetomo Nakamoto; Kazuyuki Maeno; Tetsuya Kawata; Chikara Oyama; Koji Seino; Toshinobu Sato; Shigeru Sato; Minoru Ito; Junichiro Kazama; Atsushi Ueda; Osamu Saito; Tetsuo Ando; Tomonari Ogawa; Hiroo Kumagai; Hiroyuki Terawaki; Ryoichi Ando; Masaki Abe; Tetsuya Kashiwagi; Chieko Hamada; Yugo Shibagaki; Nobuhito Hirawa; Hisaki Shimada; Yoichi Ishida; Hitoshi Yokoyama; Ryoichi Miyazaki; Mizuya Fukasawa; Yuji Kamijyo; Teppei Matsuoka; Akihiko Kato; Noriko Mori; Yasuhiko Ito; Hirotake Kasuga; Sukenari Koyabu; Tetsuro Arimura; Tetsuya Hashimoto; Masaaki Inaba; Terumasa Hayashi; Tomoyuki Yamakawa; Shinichi Nishi; Akira Fujimori; Tatsuo Yoneda; Shigeo Negi; Akihisa Nakaoka; Takafumi Ito; Hitoshi Sugiyama; Takao Masaki; Yutaka Nitta; Kazuyoshi Okada; Masahito Yamanaka; Masaharu Kan; Kazumichi Ota; Masahito Tamura; Koji Mitsuiki; Yuji Ikeda; Masaharu Nishikido; Akira Miyata; Tadashi Tomo; Shoichi Fujimoto; Tsuyoshi Nosaki; Yoshinori Oshiro, Renal Replacement Therapy, 6(1), 2020年09月
Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns, Ayumi Ishiwatari; Shungo Yamamoto; Shingo Fukuma; Takeshi Hasegawa; Sachiko Wakai; Masaomi Nangaku, American Journal of Nephrology, 51(8):650 - 658, 2020年08月
Screening tool for identifying adults with excessive salt intake among community-dwelling adults: a population-based cohort study., SASAKI S;TAKADA T;FUKUMA S;IMAMOTO M;HASEGAWA Takeshi;NISHIWAKI Hiroki;IIDA H;FUKUHARA S, Am J Clin Nutr, 111(4):814 - 820, 2020年04月, 原著, 査読あり
Estimating the Fraction of First-Year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS., KARABOYAS A;MORGENSTEM H;LI Y;BIEBER BA;HAKIN R;HASEGAWA Takeshi;JADOUL M;SCHAEFFNER E;VANHOIDER R;PISONI RL;PORT FK;ROBINSON BM, Clin Epidemiol, 12:51 - 60, 2020年01月, 原著, 査読あり
Dialysis therapy、2018 year in review 腹膜透析(PD), 長谷川 毅;伊藤 恭彦, 日本透析医学会雑誌, 52(12):759 - 760, 2019年12月
WADDA systemの使用法と有効活用, 和田 篤志;新田 孝作;花房 規男;政金 生人;阿部 雅紀;後藤 俊介;常喜 信彦;谷口 正智;中井 滋;長谷川 毅;濱野 高行;星野 純一;三浦 健一郎;山本 景一;日本透析医学会統計調査委員会, 日本透析医学会雑誌, 52(12):673 - 678, 2019年12月, 査読あり
わが国の慢性透析療法の現況(2018年12月31日現在), 新田 孝作;政金 生人;花房 規男;後藤 俊介;阿部 雅紀;中井 滋;谷口 正智;長谷川 毅;和田 篤志;濱野 高行;星野 純一;常喜 信彦;三浦 健一郎;山本 景一;中元 秀友;日本透析医学会統計調査委員会, 日本透析医学会雑誌, 52(12):679 - 754, 2019年12月, 原著, 査読あり
External validation of the quick Sequential Organ Failure Assessment score for mortality and bacteraemia risk evaluation in Japanese patients undergoing haemodialysis: a retrospective multicentre cohort study., NISHIWAKI Hiroki;SASAKI Sho;HASEGAWA Takeshi;SASAI Fumihiko;KAWARAZAKI Hiroo;MINATOGUCHI Shun;UCHIDA Daisuke;KOITABASHI Kenichiro;OZEKI Takaya;KOIWA Fumihiko;JOINT-KD collaborators, BMJ Open, 9(7):e028856, 2019年07月, 原著, 査読あり
Salt intake and body weight correlate with higher blood pressure in the very elderly population: The Sukagawa study., IIDA H;KUNTA N;TAKAHASHI S;SASAKI S;NISHIWAKI Hiroki;OMAE K;YAJIMA Nobuyuki;FUKUMA S;HASEGAWA Takeshi;FUKUHARA S;Sukagawa Study Group, J Clin Hypertens (Greenwich), 21(7):942 - 949, 2019年07月, 原著, 査読あり
Association between serum Na–Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study, Yuichi Maruta; Takeshi Hasegawa; Etsuko Yamakoshi; Hiroki Nishiwaki; Fumihiko Koiwa; Enyu Imai; Akira Hishida, Clinical and Experimental Nephrology, 23(2):215 - 222, 2019年02月
Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study., HASEGAWA Takeshi;SAKAMAKI K.;KOIWA Fumihiko;AKIZAWA Tadao;HISHIDA A., Clin Exp Nephrol, 23(2):189 - 198, 2019年02月, 原著, 査読あり
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium, Lesley A. Inker; Morgan E. Grams; Andrew S. Levey; Josef Coresh; Massimo Cirillo; John F. Collins; Ron T. Gansevoort; Orlando M. Gutierrez; Takayuki Hamano; Gunnar H. Heine; Shizukiyo Ishikawa; Sun Ha Jee; Florian Kronenberg; Martin J. Landray; Katsuyuki Miura; Girish N. Nadkarni; Carmen A. Peralta; Dietrich Rothenbacher; Elke Schaeffner; Sanaz Sedaghat; Michael G. Shlipak; Luxia Zhang; Arjan D. van Zuilen; Stein I. Hallan; Csaba P. Kovesdy; Mark Woodward; Adeera Levin; Brad Astor; Larry Appel; Tom Greene; Teresa Chen; John Chalmers; Hisatomi Arima; Vlado Perkovic; Hiroshi Yatsuya; Koji Tamakoshi; Yuanying Li; Yoshihisa Hirakawa; Kunihiro Matsushita; Yingying Sang; Kevan Polkinghorne; Steven Chadban; Robert Atkins; Ognjenka Djurdjev; Lisheng Liu; Minghui Zhao; Fang Wang; Jinwei Wang; Natalie Ebert; Peter Martus; Mila Tang; Insa Emrich; Sarah Seiler; Adam Zawada; Joseph Nally; Sankar Navaneethan; Jesse Schold; Mark Sarnak; Ronit Katz; Jade Hiramoto; Hiroyasu Iso; Kazumasa Yamagishi; Mitsumasa Umesawa; Isao Muraki; Masafumi Fukagawa; Shoichi Maruyama; Takeshi Hasegawa; Naohiko Fujii; David Wheeler; John Emberson; John Townend; Hermann Brenner; Ben Schöttker; Kai Uwe Saum; Caroline Fox; Shih Jen Hwang; Anna Köttgen; Markus P. Schneider; Kai Uwe Eckardt; Jamie Green; H. Lester Kirchner; Alex R. Chang; Kevin Ho; Sadayoshi Ito; Mariko Miyazaki; Masaaki Nakayama; Gen Yamada; Fujiko Irie; Toshimi Sairenchi; Yuichiro Yano; Kazuhiko Kotani; Takeshi Nakamura; Heejin Kimm; Yejin Mok; Gabriel Chodick; Varda Shalev; Jack F.M. Wetzels; Peter J. Blankestijn; Jan van den Brand; Barbara Kollerits, American Journal of Kidney Diseases, 73(2):206 - 217, 2019年02月
腹膜透析患者におけるエポエチンベータペゴルとダルベポエチンアルファの鉄代謝に及ぼす影響についての比較, 兼島 伸青;宮崎 友晃;笹井 文彦;長谷川 毅;小岩 文彦, 昭和学士会雑誌, 79(1):51 - 57, 2019年02月, 原著, 査読あり
The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry., NISHIWAKI Hiroki;HASEGAWA Takeshi;KOIWA Fumihiko;HAMANO T.;MASAKANE I., PLoS ONE., 14(1): e0210533, 2019年01月, 原著, 査読あり
Dialysis therapy,2017 year in review 糖尿病(DM), 長谷川 毅;稲葉 雅章, 日本透析医学会雑誌, 51(12):796 - 797, 2018年12月
Dialysis therapy,2017 year in review 腹膜透析(PD), 長谷川 毅;伊藤 恭彦, 日本透析医学会雑誌, 51(12):771 - 772, 2018年12月
わが国の慢性透析療法の現況(2017年12月31日現在), 新田 孝作;政金 生人;花房 規男;谷口 正智;長谷川 毅;中井 滋;後藤 俊介;和田 篤志;濱野 高行;星野 純一;常喜 信彦;阿部 雅紀;山本 景一;中元 秀友, 日本透析医学会雑誌, 51(12):699 - 766, 2018年12月, 査読あり
Anemia in conventional hemodialysis: Finding the optimal treatment balance., HASEGAWA Takeshi;KOIWA Fumihiko;AKIZAWA Tadao, Semin Dial, 31(6):599 - 606, 2018年11月, 総説, 査読あり
Annual Dialysis Data Report 2016, JSDT Renal Data Registry, MASAKANE I.;TANIGUCHI M.;NAKAI S.;TSUCHIDA K.;WADA A.;OGATA S.;HASEGAWA Takeshi;HAMANO T.;HANAFUSA N.;HOSHINO J.;GOTO S.;YAMAMOTO K.;MINAKUCHI J.;NAKAMOTO H., Ren Replace Ther, 4:45, 2018年11月, 原著, 査読あり
Practice pattern of physician's directions of exercise restriction in patients with chronic kidney disease: results from the Chronic Kidney Disease Japan Cohort study., NISHIWAKI Hiroki;HASEGAWA Takeshi;SHINJI Megumi;MATSUO Fujio;WATANABE Tsuyoshi;MAKINO Hirofumi;KOIWA Fumihiko;HISHIDA Akira, Clin Exp Nephrol, 22(5):1108 - 1115, 2018年10月, 原著, 査読あり
Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study., MARUTA Yuichi;HASEGAWA Takeshi;YAMAKOSHI Etsuko;NISHIWAKI Hiroki;KOIWA Fumihiko;IMAI Enyu;HISHIDA Akira, Clin Exp Nephrol, 23(2):1 - 8, 2018年08月, 原著, 査読あり
Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study., HOSHINO J.;HAMANO T.;ABE M.;HASEGAWA Takeshi;WADA A.;UBARA Y.;TAKAICHI K.;INABA M.;NAKAI S.;MASAKANE I.;Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy, Nephrol Dial Transplant, 33(7):1150 - 1158, 2018年07月, 原著, 査読あり
Dialysis-related practice patterns among dialysis patients with cancer., NISHIWAKI Hiroki;FUKUMA S.;HASEGAWA Takeshi;KIMACHI M.;AKIZAWA Tadao;FUKUHARA S., Health Sci Rep, 1(7):e46, 2018年05月, 原著, 査読あり
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis., KOVESDY CP;MATSUSHITA K.;SANG Y.;BRUNSKILL NJ;CARRERO JJ;CHODICK G.;HASEGAWA Takeshi;HEERSPIINK HL;HIRAYAMA A.;LANDMAN GWD;LEVIN A.;NITSCH D.;WHEELER DC;CORESH J.;HALLAN SI;SHALEV V.;GRAMS ME;CKD Prognosis Consortium, Eur Heart J, 39(17):1535 - 1542, 2018年05月, 原著, 査読あり
日常的な症状・状態にまつわるQ&A 腎性貧血はふつうの貧血とは違うの?どう対処するの?, 長谷川 毅;宮﨑 友晃, 透析ケア., 24(5):418, 2018年05月
腎不全の病態にまつわるQ&A なぜ末期腎不全患者は透析をしないといけないの?, 長谷川 毅;水上 礼, 透析ケア., 24(5):405, 2018年05月
Annual Dialysis Data Report 2015, JSDT Renal Data Registry., MASAKANE I.;TANIGUCHI M.;NAKAI S.;TSUCHIDA K.;GOTO S.;WADA A.;OGATA S.;HASEGAWA Takeshi;HAMANO T.;HANAFUSA N.;HOSHINO J.;MINAKUCHI J.;NAKAMOTO H., Ren Replace Ther, 4:19, 2018年03月, 原著, 査読あり
Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study., NIIHATA Kakuya;TAKAHASHI Sei;KURITA Noriaki;YAJIMA Nobuyuki;OMAE Kenji;FUKUMA Shingo;OKANO Takayuki;NOMOTO Yukio;OMORI Koichi;FUKUHARA Shunichi;Sukagawa Study Group;HASEGAWA Takeshi;IIDA Hidekazu ;KOBAYASHI Susumu;SASAKI Sho;NAGANUMA Toru ;NISHIWAKI Hiroki;TOMINAGA Ryoji, J Am Med Dir Assoc, 19(3):235 - 239, e1, 2018年03月, 原著, 査読あり
Association between post-dialysis hemoglobin level and the survival of vascular access, NISHIWAKI Hiroki;HASEGAWA Takeshi;IKENOUE T;TOMINAGA N;YAZAWA M;KAWARAZAKI H;SHIBAGAKI Y;YAMAMOTO Y;FUKUMA S;YAMAZAK S;FUKUHARA S, J Vasc Access, 19(1):69 - 75, 2018年01月, 原著, 査読あり
J-DOPPS(Japan Dialysis Outcomes and Practice Patterns Study), 長谷川 毅;逸見 治;笹井 文彦;西脇 宏樹;小岩 文彦, 腎臓内科・泌尿器科, 7(1):72 - 77, 2018年01月
わが国の慢性透析療法の現況 (2016年12月31日現在), 政金 生人;谷口 正智;中井 滋;土田 健司;和田 篤志;尾形 聡;長谷川 毅;濱野 高行;花房 規男;星野 純一;後藤 俊介;水口 潤;山本 景一;中元 秀友, 日本透析医学会雑誌, 51(1):1 - 51, 2018年01月
Dialysis therapy,2016 year in review 糖尿病(DM), 稲葉 雅章;長谷川 毅, 日本透析医学会雑誌, 50(12):768 - 769, 2017年12月
Dialysis therapy,2016 year in review 腹膜透析(PD), 伊藤 恭彦;長谷川 毅, 日本透析医学会雑誌, 50(12):747 - 749, 2017年12月
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis., RAYNER HC;LARKINA M.;WANG M.;GRAHAM-BROWN M.;van der VEER SN;ECDER T.;HASEGAWA Takeshi;KLEOPHAS W.;BIEBER BA;TENTORI F.;ROBINSON BM;PISONI RL, Clin J Am Soc Nephrol, 12(12):2000 - 2007, 2017年12月, 原著, 査読あり
【低血圧、フレイル…etc非透析患者とココが違う 透析患者の合併症ビジュアル図鑑10】 貧血, 長谷川 毅;藤岡 愛;梶谷 英人, 透析ケア, 23(9):816 - 819, 2017年09月
Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers., IMAIZUMI T;HASEGAWA Takeshi;NOMURA A;SASAKI S;NISHIWAKI Hiroki;OZEKI T;SHIMIZU H;MINATOGUCHI S;YAMAKAWA T;YAZAWA M;UCHIDA D;KAWARAZAKI H;MIYAMOTO M;SUZUKI T;KOITABASHI K;FURUSHO M;FUJITA Y, Ther Apher Dial, 21(4):354 - 360, 2017年08月, 原著, 査読あり
透析版ビッグデータの活用 J-DOPPS, 長谷川 毅;逸見 治;大宮 信哉;天笠 允仁;秋澤 忠男, 臨床透析, 33(9):1251 - 1257, 2017年08月
Correction: Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings., Sasaki S; Hasegawa T; Kawarazaki H; Nomura A; Uchida D; Imaizumi T; Furusho M; Nishiwaki H; Fukuma S; Shibagaki Y; Fukuhara S; Japanese investigatOrs with Innovative Network for; Kidney Disease; JOINT-KD, PloS one, 12(7):e0181800, 2017年07月
Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins., HASEGAWA Takeshi;ZHAO J.;FULLER D.S.;BIEBER B.;ZEE J.;MORGENSTERN H.;HANAFUSA N.;NANGAKU M., Am J Nephrol, 46(1):11 - 17, 2017年07月, 原著, 査読あり
Annual peritoneal dialysis report 2014, the peritoneal dialysis registry, Ikuto Masakane; Takeshi Hasegawa; Satoshi Ogata; Naoki Kimata; Shigeru Nakai; Norio Hanafusa; Takayuki Hamano; Kenji Wakai; Atsushi Wada; Kosaku Nitta, Renal Replacement Therapy, 3(1):21, 2017年05月
Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy., NITTA K.;MASAKANE I.;TOMO T.;TSUCHIDA K.;IKEDA K.;OGAWA T.;KANDA E.;KANNO Y.;KOMATSU Y.;TANIGUCHI M.;TAKI F.;HASEGAWA Takeshi;HANAFUSA N.;HAMANO T.;FUKAGAWA M.;MINAKUCHI J.;YAMAMOTO H.;WASHIDA N.;WADA T.;WATANABE Y., Ren Replace Ther, 3:34, 2017年05月, 原著, 査読あり
Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS., PERL J.;KARABOYAS A.;MORGENSTEN H.;SEN A.;RAYNER HC;VANHOLDER RC;COMBE C.;HASEGAWA Takeshi;FINKELSTEIN FO;LOPES AA;ROBINSON BM;PISONI RL;TENTORI F., Nephrol Dial Transplant, 32(3):521 - 527, 2017年03月, 原著, 査読あり
透析液清浄化の成果, 長谷川 毅;政金 生人, 透析フロンティア, 27(1):18 - 22, 2017年02月
Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause., SASAKI S.;KAWARAZAKI H.;HASEGAWA Takeshi;SHIMA H.;NAGANUMA T.;SHIBAGAKI Y., Nephron, 135(2):129 - 136, 2017年01月, 原著, 査読あり
Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings., SASAKI Sho;HASEGAWA Takeshi;KAWARAZAKi Hiroo;NOMURA Atsushi;UCHIDA Daisuke;IMAIZUMI Takahiro;FURUSHO Masahide;NISHIWAKI Hiroki;FUKUMA Shingo;SHIBAGAKI Yugo;FUKUHARA Shunichi;on behalf of Japanese investigatOrs with Innovative Network for Kidney Disease, PloS One, 12(1):e0169975, 2017年01月, 原著, 査読あり
わが国の慢性透析療法の現況 (2015年12月31日現在), 政金 生人;谷口 正智;中井 滋;土田 健司;後藤 俊介;和田 篤志;尾形 聡;長谷川 毅;濱野 高行;花房 規男;水口 潤;中元 秀友, 日本透析医学会雑誌, 50(1):1 - 62, 2017年01月
Dialysis therapy, 2015 year in review 2.腹膜透析(PD), 長谷川 毅;伊藤 恭彦, 日本透析医学会雑誌, 49(12):767 - 768, 2016年12月
Dialysis therapy, 2015 year in review 9.糖尿病(DM), 長谷川 毅;稲葉 雅章, 日本透析医学会雑誌, 49(12):787 - 788, 2016年12月
Peritoneal Dialysis Registry With 2013 Survey Report, MASAKANE I.;HASEGAWA Takeshi;OGATA S.;KIMATA N.;NAKAI S.;HANAFUSA N.;HAMANO T.;WAKAI K.;WADA A.;NITTA K., Ther Apher Dial, 20(6):557 - 568, 2016年12月, 原著, 査読あり
Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study, KOMUKAI Daisuke;HASEGAWA Takeshi;KANESHIMA Nobuharu;TAKAYASU Mamiko;SATO Yoshinori;HIROSE M.;YOSHIMURA Ashio, Nephrology, 21(10):887 - 892, 2016年10月, 原著, 査読あり
高齢透析患者の生命予後、合併症、QOL、ADL HDとPD、エビデンスの整理 QOL、ADL, 飯田 英和;長谷川 毅, 臨床透析, 32(10):1277 - 1284, 2016年09月
日本透析医学会診療ガイドライン(CPG)作成指針, 新田 孝作;政金 生人;友 雅司;土田 健司;池田 潔;小川 智也;神田 英一郎;菅野 義彦;小松 康宏;谷口 正智;瀧 史香;長谷川 毅;花房 規男;濱野 高行;深川 雅史;水口 潤;山本 裕康;鷲田 直輝;和田 隆志;渡邊 有三, 日本透析医学会雑誌, 49(7):453 - 462, 2016年07月
Early mortality was highly and strongly associated with functional status in incident Japanese hemodialysis patients: A cohort study of the large national dialysis registry, YAZAWA M.;KIDO R.;OHIRA S.;HASEGAWA Takeshi;HANAFUSA N.;ISEKI K.;TSUBAKIHARA Y.;SHIBAGAKI Y., PloS One, 11(6):e0156951, 2016年06月, 原著, 査読あり
Exploratory investigation of factors associated with new-onset peripheral arterial disease (pad) in non-diabetic hemodialysis patients, Makoto Hirose; Takeshi Hasegawa; Fumihiko Koiwa; Ashio Yoshimura, Journal of the Showa Medical Association, 76(2):187 - 192, 2016年04月, 原著, 査読あり
PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism, AKIZAWA Tadao;KURITA N.;MIZOBUCHI Masahide;FUKAGAWA M.;ONISHI Y.;YAMAGUCHI T.;ELLIS A. R.;FUKUMA S.;ALAN BROOKHART M.;HASEGAWA Takeshi;KUROKAWA K.;FUKUHARA S., Sci Rep, 6:19612, 2016年04月, 原著, 査読あり
非糖尿病血液透析患者における末梢動脈疾患 (Peripheral Arterial Disease:PAD) の新規発症に影響を及ぼす因子の探索的検討 , 廣瀬 真;長谷川 毅;小岩 文彦;吉村 吾志夫, 昭和学士会雑誌,
76(2):187 - 192, 2016年04月,
原著,
査読あり,
DOI:10.14930/jshowaunivsoc.76.187 Serum creatinine modifies associations between body mass index and mortality and morbidity in prevalent hemodialysis patients, SAKAO Y.;OJIMA T.;YASUDA H.;HASHIMOTO S.;HASEGAWA Takeshi;ISEKI K.;TSUBAKIHARA Y.;KATO A., PloS One, 11(3):e0150003, 2016年03月, 原著, 査読あり
A single-hospital, descriptive study of patients with acute kidney injury requiring continuous renal replacement therapy, Mamiko Takayasu; Hiroki Nishiwaki; Daisuke Komukai; Takeshi Hasegawa; Ashio Yoshimura, Journal of the Showa Medical Association, 76(1):43 - 51, 2016年02月
Dialysis therapy, 2014 year in review 2. 腹膜透析 (PD), 伊藤 恭彦;長谷川 毅, 日本透析医学会雑誌, 49(2):167 - 169, 2016年02月
Dialysis therapy, 2014 year in review 8. 糖尿病 (DM), 長谷川 毅;稲葉 雅章, 日本透析医学会雑誌, 49(2):183 - 184, 2016年02月
腹膜透析(PD)レジストリ2014年末調査報告, 政金 生人;長谷川 毅;尾形 聡;木全 直樹;中井 滋;花房 規男;濱野 高行;若井 建志;和田 篤志;新田 孝作, 日本透析医学会雑誌, 49(1):35 - 45, 2016年01月
Peritoneal Dialysis Registry With 2012 Survey Report, HASEGAWA Takeshi;NAKAI S.;MORISHI M.;ITO Y.;ITAMI N.;MASAKANE I.;HANAFUSA N.;TANIGUCHI M.;HAMANO T.;SHOJI T.;YAMAGATA K.;SHINODA T.;KAZAMA J.;WATANABE Y.;SHIGEMATSU T.;MARUBAYASHI S.;MORITA O.;WADA A.;HASHIMOTO S.;SUZUKI K.;KIMATA N.;WAKAI K.;FUJII N.;OGATA S.;TSUCHIDA K.;NISHI H.;ISEKI K.;TSUBAKIHARA Y.;NAKAMOTO H., Ther Apher Dial, 19(6):529 - 539, 2015年12月, 原著, 査読あり
透析患者と疲労 健康関連QOLと疲労感, 長谷川 毅, 臨床透析, 31(12):1505 - 1511, 2015年11月
Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsilectiomy plus steroid pulse therapy., NAGAYAMA Yoshikuni;NISHIWAKI Hiroki;HASEGAWA Takeshi;KOMUKAI Daisuke;KAWASHIMA Eri;TAKAYASU Mamiko ;TAYAMA Hironori;INOUE Yoshihiko;INUI Kiyoko;YOSHIMURA Ashio, Clin Exp Nephrol, 19(4):646 - 652, 2015年08月, 原著, 査読あり
Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: A nationwide cohort study, Takeshi Hasegawa; Shigeru Nakai; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara; Tadao Akizawa, American Journal of Kidney Diseases, 65(6):899 - 904, 2015年06月, 原著, 査読あり
Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin A nephropathy., NISHIWAKI Hiroki;HASEGAWA Takeshi;NAGAYAMA Yoshikuni;KANESHIMA Nobuharu;TAKAYASU Mamiko;HIROSE Makoto;KOMUKAI Daisuke;INOUE Yoshihiko;KOIWA Fumihiko;YOSHIMURA Ashio, Nephron, 130(1):1 - 7, 2015年04月, 原著, 査読あり
The association between onset age and long-term prognosis in patients with adult-onset minimal change nephrotic syndrome, Daisuke Komukai; Ashio Yoshimura; Takeshi Hasegawa; Makoto Hirose, Journal of the Showa Medical Association, 75(1):70 - 77, 2015年02月
腹膜透析(PD)レジストリ2013年末調査報告, 政金 正人;長谷川 毅;尾形 聡;木全 直樹;中井 滋;花房 規男;濱野 高行;若井 建志;和田 篤志;新田 孝作, 日本透析医学会雑誌, 48(1):33 - 44, 2015年01月, 原著
Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients, Norio Hanafusa; Takanobu Nomura; Takeshi Hasegawa; Masaomi Nangaku, NEPHROLOGY DIALYSIS TRANSPLANTATION, 29(12):2316 - 2326, 2014年12月, 原著, 査読あり
Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS., LOPES Antonio Alberto;LANTZ Brett;MORGENSTERN Hal;WANG Mia;BIEBER Brian A;GILLESPIE Brenda W;LI Yun;PAINTER Patricia;JACOBSON Stefan H;RAYNER Hugh C;MAPES Donna L;VANHOLDER Raymond C;HASEGAWA Takeshi;ROBINSON Bruce M;PISONI Ronald L, Clin J Am Soc Nephrol, 9(10):1702 - 1712, 2014年10月, 原著, 査読あり
Recovery Time, Quality of Life, and Mortality in Hemodialysis Patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)., RAYNER Hugh C;ZEPEL Lindsay;FULLER Douglas S;MORGENSTERn Hal;KARABOYAS Angelo;CULLETON Bruce F;MAPES Donna L;LOPES Antonio A;GILLESPIE Brenda W;HASEGAWA Takeshi;SARAN Rajiv;TENTORI Francesca;HECKING Manfred;PISONI Ronald L;ROBINSON Bruce M, Am J Kidney Dis, 64(1):86 - 94, 2014年07月, 原著, 査読あり
Abnormal Mineral Metabolism and Mortality in Hemodialysis Patients With Secondary Hyperparathyroidism: Evidence From Marginal Structural Models Used to Adjust for Time-Dependent Confounding., FUKAGAWA Masafumi;KIDO Ryo;KOMABA Hirotaka;ONISHI Yoshihiro;YAMAGUCHI Takuhiro;HASEGAWA Takeshi;KURITA Noriaki;FUKUMA Shingo;AKIZAWA Tadao;FUKUHARA Shunichi, Am J Kidney Dis, 63(6):979 - 987, 2014年06月, 原著, 査読あり
An overview of regular dialysis treatment in Japan (as of 31 December 2012)., NAKAI Shigeru;HANAFUSA Norio;MASAKANE Ikuto;TANIGUCHI Masatomo;HAMANO Takayuki;SHOJI Tetsuo;HASEGAWA Takeshi;ITAMI Noritomo;YAMAGATA Kunihiro;SHINODA Toshio;KAZAMA Junichiro James;WATANABE Yuzo;SHIGEMATSU Takashi;MARUBAYASHI Seiji;MORITA Osamu;WADA Atsushi;HASHIMO Seiji;SUZUKI Kazuyuki;NAKAMOTO Hidetomo;KIMATA Naoki;WAKAI Kenji;FUJII Naohiko;OGATA Satoshi ;TSUCHIDA Kenji;NISHI Hiroshi;ISEKI Kunitoshi;TSUBAKIHARA Yoshiharu, Ther Apher Dial, 18(6):535 - 602, 2014年06月, 原著, 査読あり
透析 検査項目とスケジュール 導入時に必要な検査, 長谷川 毅;兼島 伸青;前住 忠秀, 腎と透析, 76(増刊):238 - 241, 2014年06月
腹膜透析(PD)レジストリ2012年末調査報告, 長谷川 毅;中井 滋;森石 みさき;伊藤 恭彦;伊丹 儀友;政金 生人;花房 規男;谷口 正智;濱野 高行;庄司 哲雄;山縣 邦弘;篠田 俊雄;風間 順一郎;渡邊 有三;重松 隆;丸林 誠二;守田 治;和田 篤志;橋本 整司;鈴木 一之;木全 直樹;若井 建志;藤井 直彦;尾形 聡;土田 健司;西 裕志;井関 邦敏;椿原 美治;中元 秀友, 日本透析医学会雑誌, 47(2):107 - 117, 2014年02月
わが国の慢性透析療法の現況(2012年12月31日現在), 中井 滋;花房 規男;政金 生人;谷口 正智;濱野 高行;庄司 哲雄;長谷川 毅;伊丹 儀友;山縣 邦弘;篠田 俊雄;風間 順一郎;渡邊 有三;重松 隆;丸林 誠二;守田 治;和田 篤志;橋本 整司;鈴木 一之;中元 秀友;木全 直樹;若井 建志;藤井 直彦;尾形 聡;土田 健司;西 裕志;井関 邦敏;椿原 美治;日本透析医学会統計調査委員会統計解析小委員会, 日本透析医学会雑誌, 47(1):1 - 56, 2014年01月, 原著
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011), NAKAI S.;WATANABE Y.;MASAKANE I.;WADA A.;SHOJI T.;HASEGAWA Takeshi;NAKAMOTO H.;YAMAGATA K.;KAZAMA J.J.;FUJII N.;ITAMI N.;SHINODA T.;SHIGEMATSU T.;MARUBAYASHI S.;MORITA O.;HAHSIMOTO S.;SUZUKI K.;KIMATA N.;HANAFUSA N.;WAKAI K.;HAMANO T.;OGATA S.;TSUCHIDA K.;TANIGUCHI M.;NISHI H.;ISEKI K.;TSUBAKIHARA Y., Ther Apher Dial, 17(6):567 - 611, 2013年12月, 原著, 査読あり
Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma, SHOJI K.;MURAYAMA T.;MIMURA I.;WADA T.;KUME H.;GOTO A.;OHSE T.;TANAKA T.;INAGI R.;van der HOOMn F.A.;MANABE I.;HOMMA Y.;FUKAYAMA M.;SAKURAI T.;HASEGAWA Takeshi;ABURATANI H.;KODAMA T.;NANGAKU M., Am J Pathol, 182(6):2191 - 2203, 2013年06月, 原著, 査読あり
【透析療法up-date】 治療法、透析処方と予後, 長谷川 毅;高安 真美子;西脇 宏樹, 腎と透析, 74(5):886 - 892, 2013年05月
Interpersonal Psychosocial Factors Associated With Underreported Dietary Energy Intake in Hemodialysis Patients, YOKOYAMA Y.;SASAKI S.;SUZUKAMO Y.;YAMAZAKI S.;TAKEGAMI M.;KAKUDATE N.;HASEGAWA Takeshi;HAGA M.;KAWAGUCHI T.;MORIYA T.;HOTTA O.;FUKUHARA S.;Dialysis Nutrition Research Group, J Ren Nutr, 23(1):37 - 44, 2013年01月, 原著, 査読あり
わが国の慢性透析療法の現況(2011年12月31日現在), 中井 滋;渡邊 有三;政金 生人;和田 篤志;庄司 哲雄;長谷川 毅;中元 秀友;山縣 邦弘;風間 順一郎;藤井 直彦;伊丹儀友;篠田 俊雄;重松 隆;丸林 誠二;守田 治;橋本 整司;鈴木 一之;木全 直樹;花房 規男;若井 建志;濱野 高行;尾形 聡;土田 健司;谷口 正智;西 裕志;井関 邦敏;椿原 美治, 日本透析医学会雑誌, 46(1):1 - 76, 2013年01月, 原著
An overview of regular dialysis treatment in Japan (as of 31 December 2010), NAKAI S.;ISEKI K.;ITAMI N.;OGATA S.;KAZAMA J.J.;KIMATA N.;SHIGEMATSU T.;SHINODA T.;SHOJI T.;SUZUKI K.;TANIGUCHI M.;TSUCHIDA K.;NAKAMOTO H.;NISHI H.;HASHIMOTO S.;HASEGAWA Takeshi;HANAFUSA N.;HAMANO T.;FUJII N.;MASAKANE I.;MARUBAYASHI S.;MORITA O.;YAMAGATA K.;WAKAI K.;WADA A.;WATANABE Y.;TSUBAKIHARA Y., Ther Apher Dial, 16(6):483 - 521, 2012年12月, 原著, 査読あり
Reduced survival and quality of life following return to dialysis after transplant failure: The Dialysis Outcomes and Practice Patterns Study, PERL J.;ZHANG J.;GILLERSPIE B;WIKSTROM B.;FORT J.;HASEGAWA Takeshi;FULLER D.S.;PISONI R.L.;ROBINSON B.M.;TENTORI F., Nephrol Dial Transplant, 27(12):4464 - 4472, 2012年12月, 原著, 査読あり
導入時高齢患者の予後, 谷澤 雅彦;柴垣 有吾;長谷川 毅;花房 規男, 日本透析医会雑誌, 27(3):425 - 431, 2012年12月, 査読あり
血液疾患薬 エリスロポエチン産生刺激製剤, 長谷川 毅;笹井 文彦;藤岡 礼, Medicina, 49(11):274 - 277, 2012年11月
Prescription patterns and mineral metabolism abnormalities in the cinacalcet Era: Results from the MBD-5D study, FUKAGAWA M.;FUKUMA S.;ONISHI Y.;YAMAGUCHI T.;HASEGAWA Takeshi;AKIZAWA Tadao;KUROKWA K.;FUKUHARA S., Clin J Am Soc Nephrol, 7(9):1473 - 1480, 2012年09月, 原著, 査読あり
Overview of regular dialysis treatment in Japan (as of 31 December 2009), NAKAI S.;ISEKI K.;ITAMI N.;OGATA S.;KAZAMA J.J.;KIMATA N.;SHIGEMATSU T.;SHINODA T.;SHOJI T.;SSUZUKI K.;TANIGUCHI M.;TSUCHIDA K.;NAKAMOTO H.;NISHI H.;HASHIMOTO S.;HASEGAWA Takeshi;HANAFUSA N.;HAMANO T.;FUJII N.;MASAKANE I.;MARUBAYASHI S.;MORITA O.;YAMAGATA K.;WAKAI K.;WADA A.;WATANABE Y.;TSUBAKIHARA Y., Ther Apher Dial, 16(1):11 - 53, 2012年02月, 原著, 査読あり
Mortality of Japanese dialysis patients versus US counterparts, Takeshi Hasegawa; Eriko Kinugasa; Tadao Akizawa, Dialysis: History, Development and Promise, :647 - 656, 2012年01月
わが国の慢性透析療法の現況(2010年12月31日現在), 中井 滋;井関 邦敏;伊丹 儀友;尾形 聡;風間 順一郎;木全 直樹;重松 隆;篠田 俊雄;庄司 哲雄;鈴木 一之;谷口 正智;土田 健司;中元 秀友;西 裕志;橋本 整司;長谷川 毅;花房 規男;濱野 高行;藤井 直彦;政金 生人;丸林 誠二;守田 治;山縣 邦弘;若井 建志;和田 篤志;渡邊 有三;椿原 美治, 日本透析医学会雑誌, 45(1):1 - 47, 2012年01月, 原著
Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: Associations with changing practice patterns, AKIZAWA Tadao;KIDO R.;FUKAGAWA M.;ONISHI Y.;YAMAGUCHI T.;HASEGAWA Takeshi;FUKUHARA S.;KUROKAWA K., Clin J Am Soc Nephrol, 6(9):2280 - 2288, 2011年09月, 原著, 査読あり
腎性貧血治療目標としての健康関連QOLの意義, 長谷川 毅;丸田 雄一, 腎と透析, 71(2):253 - 259, 2011年08月
Mineral and Bone Disorders Outcomes Study for Japanese Chronic Kidney Disease Stage 5D Patients: Rationale and Study Design, FUKUHARA S.;AKIZAWA Tadao;FUKAGAWA M.;ONISHI Y.;YAMAGUCHI T.;HASEGAWA Takeshi;KUROKAWA K., Ther Apher Dial, 15(2):169 - 175, 2011年04月, 原著, 査読あり
透析医療を科学する臨床研究デザイン 抄録道場 第55回日本透析医学会パネルディスカッションより, 長谷川 毅;佐田 憲英;柴垣 有吾;福原 俊一;秋澤 忠男, 日本透析医学会雑誌, 44(3):221 - 227, 2011年03月
Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin, HASEGAWA Takeshi;BRAGG-GRESHAM J.L.;PISONI R.L.;ROBINSON B.M.;FUKUHARA S.;AKIBA T.;SAITO A.;KUROKAWA K.;AKIZAWA Tadao, Kidney Int, 79(3):340 - 346, 2011年02月, 原著, 査読あり
腎性貧血治療と健康関連QOL, 長谷川 毅;保坂 望, Prog Med, 31(2):421 - 427, 2011年02月
わが国の慢性透析療法の現況(2009年12月31日現在), 中井 滋;井関 邦敏;伊丹 儀友;尾形 聡;風間 順一郎;木全 直樹;重松 隆;篠田 俊雄;庄司 哲雄;鈴木 一之;谷口 正智;土田 健司;中元 秀友;西 裕志;橋本 整司;長谷川 毅;花房 規男;濱野 高行;藤井 直彦;政金 生人;丸林 誠二;守田 治;山縣 邦弘;若井 建志;和田 篤志;渡邊 有三;椿原 美治, 日本透析医学会雑誌, 44(1):1 - 36, 2011年01月, 原著
Overview of regular dialysis treatment in Japan (as of 31 December 2008), NAKAI S.;SUZUKI K.;MASAKANE I.;WADA A.;ITAMI N.;OGATA S.;KIMATA N.;SHIGEMATSU T.;SHINODA T.;SYOUJI T.;TANIGUCHI M.;TSUCHIDA K.;NAKAMOTO H.;NISHI S.;NISHI H.;HASHIMOTO S.;HASEGAWA Takeshi;HANAFUSA N.;HAMANO T.;FUJII N.;MARUBAYASHI S.;MORITA O.;YAMAGATA K.;WAKAI K.;WATANABE Y.;ISEKI K.;TSUBAKIHARA Y., Ther Apher Dial, 14(6):505 - 540, 2010年12月, 原著, 査読あり
In reply to predialytic period and baseline peritoneal membrane status: Any connection?, 長谷川 毅;KOIWA F.;YAMAZAKI S.;YOSHIMURA A., Perit Dial Int, 30(4):478 - 480, 2010年08月, 査読あり
An overview of regular dialysis treatment in Japan (as of 31 December 2007), Shigeru Nakai; Ikuto Masakane; Takashi Shigematsu; Takayuki Hamano; Kunihiro Yamagata; Yuuzou Watanabe; Noritomo Itami; Satoshi Ogata; Naoki Kimata; Toshio Shinoda; Tetsuo Syouji; Kazuyuki Suzuki; Masatomo Taniguchi; Kenji Tsuchida; Hidetomo Nakamoto; Shinichi Nishi; Hiroshi Nishi; Seiji Hashimoto; Takeshi Hasegawa; Norio Hanafusa; Naohiko Fujii; Seiji Marubayashi; Osamu Morita; Kenji Wakai; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara, Therapeutic Apheresis and Dialysis, 13(6):457 - 504, 2009年12月
Impact of early referral to nephrologist on mental health among hemodialysis patients: A dialysis outcomes and practice patterns study (DOPPS), Yoko Yokoyama; Shin Yamazaki; Takeshi Hasegawa; Takafumi Wakita; Yasuaki Hayashino; Misa Takegami; Takashi Akiba; Tadao Akizawa; Yasushi Asano; Akira Saito; Kiyoshi Kurokawa; Shunichi Fukuhara, Nephron - Clinical Practice, 113(3):C191 - C197, 2009年10月
Dialysis staff encouragement and fluid control adherence in patients on hemodialysis., Yoko Yokoyama; Yoshimi Suzukamo; Osamu Hotta; Shin Yamazaki; Takehiko Kawaguchi; Takeshi Hasegawa; Shigemi Chiba; Toshiko Moriya; Emi Abe; Satoshi Sasaki; Megumi Haga; Shunichi Fukuhara, Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 36(3):289 - 297, 2009年05月
Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits, Takeshi Hasegawa; Jennifer L. Bragg-Gresham; Shin Yamazaki; Shunichi Fukuhara; Tadao Akizawa; Werner Kleophas; Roger Greenwood; Ronald L. Pisoni, Clinical Journal of the American Society of Nephrology, 4(3):595 - 602, 2009年03月
A strict low protein diet during the predialysis period suppresses peritoneal permeability at induction of peritoneal dialysis, Takeshi Hasegawa; Ahio Yoshimura; Makoto Hirose; Daisuke Komukai; Hironori Tayama; Susumu Watanabe; Fumihiko Koiwa; Shin Yamazaki; Terukuni Ideura, Peritoneal Dialysis International, 29(3):319 - 324, 2009年
Vascular access use and outcomes: An international perspective from the dialysis outcomes and practice patterns study (Nephrology Dialysis Transplantation (2008) DOI: 10.1093/ndt/gfn261), Jean Ethier; David C. Mendelssohn; Stacey J. Elder; Takeshi Hasegawa; Tadao Akizawa; Takashi Akiba; Bernard J. Canaud; Ronald L. Pisoni, Nephrology Dialysis Transplantation, 23(12):4088 - 3226, 2008年12月
Japanese haemodialysis anaemia management practices and outcomes (1999-2006): Results from the DOPPS, Tadao Akizawa; Ronald L. Pisoni; Takashi Akiba; Akira Saito; Shunichi Fukuhara; Yasushi Asano; Takeshi Hasegawa; Friedrich K. Port; Kiyoshi Kurokawa, Nephrology Dialysis Transplantation, 23(11):3643 - 3653, 2008年11月
Vascular access use and outcomes: An international perspective from the dialysis outcomes and practice patterns study, Jean Ethier; David C. Mendelssohn; Stacey J. Elder; Takeshi Hasegawa; Tadao Akizawa; Takashi Akiba; Bernard J. Canaud; Ronald L. Pisoni, Nephrology Dialysis Transplantation, 23(10):3219 - 3226, 2008年10月
Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study, Takeshi Hasegawa; Stacey J. Elder; Jennifer L. Bragg-Gresham; Ronald L. Pisoni; Shin Yamazaki; Tadao Akizawa; Michel Jadoul; Rayner C. Hugh; Friedrich K. Port; Shunichi Fukuhara, Clinical Journal of the American Society of Nephrology, 3(5):1373 - 1378, 2008年09月
Indication and efficacy of PEIT in the management of secondary hyperparathyroidism, Fumihiko Koiwa; Takeshi Hasegawa; Reika Tanaka; Takatoshi Kakuta, NDT Plus, 1(SUPPL.3):iii14 - iii17, 2008年08月
保存期慢性腎不全患者におけるSF‐36v2日本語acute版の計量心理学的検証, 長谷川毅; 鈴鴨よしみ; 秋澤忠男; 福原俊一, 日本腎臓学会誌, 50(1):42 - 50, 2008年
Indication of parathyroid intervention, Fumihiko Koiwa; Takeshi Hasegawa, Clinical calcium, 17(5):760 - 766, 2007年05月
副甲状腺インターベンションの適応, 小岩文彦、長谷川毅, クリニカルカルシウム, 17(5):760 - 766, 2007年05月, 総説
Mixed cryoglobulinemia due to chronic hepatitis C with severe pulmonary involvement, Ryuji Suzuki; Hiroyuki Morita; Daisuke Komukai; Takeshi Hasegawa; Naoyuki Nakao; Terukuni Ideura; Ashio Yoshimura, Internal Medicine, 42(12):1210 - 1214, 2003年12月
Time course of change in calcium x phosphorus product after percutaneous ethanol injection therapy, Fumihiko Koiwa; Takeshi Hasegawa; Ichiro Kojima; Terekuni Ideura, Nephrology Dialysis Transplantation, 18(SUPPL. 3):53 - 57, 2003年06月
Adult staphylococcus scalded skin syndrome in a peritoneal dialysis patient, Ryuji Suzuki; Shigeki Iwasaki; Yukie Ito; Takeshi Hasegawa; Tatuo Yamamoto; Terukuni Ideura; Ashio Yoshimura, Clinical and Experimental Nephrology, 7(1):77 - 80, 2003年03月
Collagenofibrotic glomerulopathy with a widespread expression of type-V collagen, Hiroyuki Morita; Takeshi Hasegawa; Toshinari Minamoto; Yoshio Oda; Kiyoko Inui; Hironori Tayama; Naoyuki Nakao; Yasushi Nakamoto; Terukuni Ideura; Ashio Yoshimura, Virchows Archiv, 442(2):163 - 168, 2003年02月